Howard W. Robin
2007
In 2007, Howard W. Robin earned a total compensation of $2.2M as President and Chief Executive Officer at Nektar Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $601,800 |
|---|---|
| Option Awards | $967,644 |
| Salary | $654,243 |
| Other | $4,083 |
| Total | $2,227,770 |
Robin received $967.6K in option awards, accounting for 43% of the total pay in 2007.
Robin also received $601.8K in non-equity incentive plan, $654.2K in salary and $4.1K in other compensation.
Rankings
In 2007, Howard W. Robin's compensation ranked 2,083rd out of 8,700 executives tracked by ExecPay. In other words, Robin earned more than 76.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,083 out of 8,700 | 76th |
Division Manufacturing | 708 out of 3,314 | 79th |
Major group Chemicals And Allied Products | 134 out of 746 | 82nd |
Industry group Drugs | 72 out of 546 | 87th |
Industry Pharmaceutical Preparations | 55 out of 364 | 85th |
Source: SEC filing on April 29, 2009.
Robin's colleagues
We found eight more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2007.
2007
Robert Chess
Nektar Therapeutics
Chief Executive Officer
2007
Hoyoung Huh
Nektar Therapeutics
Chief Operating Officer
2007
David Johnston
Nektar Therapeutics
Former Senior Vice President Research and Development
2007
Timothy Harkness
Nektar Therapeutics
Chief Financial Officer
2007
Nevan Elam
Nektar Therapeutics
Senior Vice President and Head of the Pulmonary Business Unit
2007
Louis Drapeau
Nektar Therapeutics
Chief Financial Officer
2007
John Patton
Nektar Therapeutics
Chief Research Fellow
2007
John Nicholson
Nektar Therapeutics